In colorectal cancer (CRC), alterations in WNT, c‐Myc, and KRAS signaling have all been shown to result in the dysregulation of translational, which is essential for intestinal tumorigenesis [14, 15, 16]. Here, KRAS is linked to colorectal carcinoma.